Sequent Scientific - Quaterly Results

07 Nov 2022 Evaluate
The Revenue for the quarter ended  September 2022 of Rs. 542.31 millions grew by 8.23 % from Rs. 501.05 millions.The Net Loss for the quarter ended September 2022 is Rs. -40.50 millions as compared to Net Profit of Rs. 42.87 millions of corresponding quarter ended September 2021Operating profit Margin for the quarter ended September 2022 slipped to -28.53% as compared to 58.29% of corresponding quarter ended September 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 542.31 501.05 8.23 1190.91 967.62 23.08 2196.26 2654.57 -17.26
Other Income 67.26 104.11 -35.40 126.06 161.74 -22.06 276.43 199.66 38.45
PBIDT -28.53 58.29 -148.94 10.37 74.31 -86.04 268.93 552.56 -51.33
Interest 5.75 2.79 106.09 9.29 4.46 108.30 16.10 26.80 -39.93
PBDT -34.28 55.50 -161.77 1.08 69.85 -98.45 252.83 500.15 -49.45
Depreciation 22.49 25.40 -11.46 46.30 48.48 -4.50 95.93 91.28 5.09
PBT -56.77 30.10 -288.60 -45.22 21.37 -311.61 156.90 408.87 -61.63
TAX -16.27 -12.77 27.41 -13.12 -15.41 -14.86 8.91 87.74 -89.84
Deferred Tax -14.37 6.13 -334.42 -13.32 5.07 -362.72 5.20 26.89 -80.66
PAT -40.50 42.87 -194.47 -32.10 36.78 -187.28 147.99 321.13 -53.92
Equity 498.87 496.74 0.43 498.87 496.74 0.43 496.74 496.74 0.00
PBIDTM(%) -5.26 11.63 -145.22 0.87 7.68 -88.66 12.24 20.82 -41.17

Sequent Scientific Share Price

122.85 -0.60 (-0.49%)
14-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1515.00
Dr. Reddys Lab 6080.25
Cipla 1565.50
Zydus Lifesciences 1110.95
Lupin 1601.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.